Clinical Study

Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma

Table 3

Multivariate analysis of factors affecting recurrence-free survival after OLT in patients with HCC.

P valueOdds RatioC.I. 95%

AFP > 30 ng/mL at OLT.0032.881.43–5.80
Pre-OLT treatments.014.841.42–16.42
Histological up-to-7.70.840.32–2.18
Grading.41.430.56–3.65
Microvascular invasion.0014.821.87–12.41

OLT: orthotopic liver transplantation. HCC: hepatocellular carcinoma. AFP: alpha-fetoprotein.